As neurological disorders frequently manifest elevated levels of reactive oxygen species (ROS), deriving in-part from the cytokine-dependent activation of endothelial NADPH oxidase [16]–[18], the contribution of cytokine-induced NADPH oxidase activation and ROS generation to HBMvEC barrier properties was also investigated. This evidence concerns the gene FMO5 and nervous system disorder.